Consensus recommendations for the prevention of cervical cancer in sub-Saharan Africa
Date
2013Author
Adewole, I.F.
Abauleth, Y.R.
Adoubi, I.
Amorissani, F.
Anorlu, R.I.
Awolude, O.A.
Botha, H.
Byamugisha, J.K.
Cisse, L.
Diop, M.
Doh, S.
Fabamwo, A.O.
Gahouma, D.
Galadanci, H.S.
Githanga, D.
Magure, T.M.
Mabogunje, C.
Mbuthia, J.
Muchiri, L.w.
Ndiaye, O.
Nyakabau, A.M.
Ojwang, S.B.O.
Ramogola-Masire, D.
Sekyere, O.
Smith, T.H.
Taulo, F.O.G.
Wewege, A.
Wiredu, E.
Yarosh, O.
Publisher
MedPharm Publications (Medical Pharmaceutical Publishers), http://www.sajgo.co.za/Rights holder
Publishers - MedPharm Publications and South African Society of Gynaecologic OncologyType
Published ArticleMetadata
Show full item recordAbstract
Cervical cancer is the second most common cancer and the leading cause of cancer-related death in women in
sub-Saharan Africa. It is estimated that more than 200 million females older than 15 years are at risk in this region. This paper highlights the current burden of cervical cancer in sub-Saharan Africa, reviews the latest clinical data on primary prevention, outlines challenges in the region, and offers potential solutions to these barriers. Based on these factors, clinical recommendations for the prevention of cervical cancer from the sub-Saharan African Cervical Cancer Working Group expert panel are presented.